Comparison of efficacy of brivaracetam and oxcarbazepine in children with epilepsy
Phase 2
- Conditions
- Health Condition 1: G400- Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset
- Registration Number
- CTRI/2023/04/051602
- Lead Sponsor
- Diksha Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed cases of focal epilepsy
Exclusion Criteria
Co-existent generalized seizure
History of allergy to either brivaracetam or oxcarbazepine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of participants who remain seizure free in both groupsTimepoint: At6-months
- Secondary Outcome Measures
Name Time Method umber of participants achieving at least 50% reduction in seizure frequencyTimepoint: At-6 months